Riskpilot← Back to searchSign inGet full accessApotekerna LEM AB
ABActiveOrg 5591672422Hallängen 5Retail sale of pharmaceutical products · NACE 4773Est. 20184 employees
Revenue 2025
SEK 29,8M
+7% vs 2024
EBITDA margin
3.9%
+5% vs 2024
Equity ratio
50.1%
Financial strength
Net profit 2025
SEK 829K
+3% vs 2024
| Revenue | SEK 29,8M | +7% |
| EBITDA | SEK 1,2M | +5% |
| Net profit | SEK 829K | +3% |
| Total assets | SEK 7M | +14% |
| Equity | SEK 3,5M | +13% |
| Employees | 4 | — |
Legal name
Apotekerna LEM AB
Org number
5591672422
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
3 augusti 2018
Share capital
SEK 50 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Bolaget ska bedriva handel med apoteksvaror.
Address
Hallängen 5
Email
apotekosmo@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 27 369 | 28 396 | 26 162 | 27 738 | 29 815 |
| Staff expenses | — | — | −3 967 | −3 343 | −2 460 |
| EBITDA | 318 | 1 637 | 770 | 1 100 | 1 155 |
| Depreciation & amort. | −140 | −128 | −128 | −31 | −61 |
| EBIT | 178 | 1 509 | 642 | 1 068 | 1 094 |
| Net financials | −126 | −129 | 2 | −48 | −16 |
| Profit before tax | 52 | 1 380 | 644 | 1 020 | 1 078 |
| Tax | −27 | −291 | −130 | −213 | −250 |
| Net profit | 25 | 1 089 | 514 | 808 | 829 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 6 434 | 6 592 | 5 580 | 6 108 | 6 978 |
| Equity | 1 876 | 2 965 | 2 679 | 3 087 | 3 498 |
| Long-term debt | 1 750 | 993 | 463 | 265 | 286 |
| Short-term debt | 2 809 | 2 634 | 2 438 | 2 755 | 3 193 |
| Total debt | 4 559 | 3 627 | 2 901 | 3 020 | 3 480 |
EBITDA margin
3.9%
This company
15.8%
Market median
-75% vs market
20212025
Equity ratio
50.1%
This company
38.2%
Market median
+31% vs market
20212025
Return on equity
23.7%
This company
18.4%
Market median
+29% vs market
20212025
Net profit margin
2.8%
This company
8.1%
Market median
-65% vs market
20212025
Asset turnover
4.27×
This company
1.12×
Market median
+281% vs market
20212025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TM Audit | Audit | 2020 |
| Former (2) | ||
MK Chief Auditor | Chief Auditor | 2022 – 2022 |
KE Chief Auditor | Chief Auditor | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Apotekerna LEM AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tony Mikael Salonen | Audit | 0 companies |
| Maria Kersti Theander | Chief Auditor | 0 companies |
| Karl Erik Sebastian Schelander | Chief Auditor | 0 companies |
| Mithal Kassem | Deputy Board Member | 0 companies |
| Hilal Kassem | Board of Directors | 0 companies |
| Kamal Kassem | Chairman | 0 companies |